Stryker (BSP:S1YK34) YoY EBITDA Growth : 12.20% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Stryker YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Stryker's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was 12.20%.

Stryker's EBITDA per Share for the three months ended in Dec. 2023 was R$0.97.

Stryker YoY EBITDA Growth Historical Data

The historical data trend for Stryker's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stryker YoY EBITDA Growth Chart

Stryker Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

18.74

3.72

31.73

1.95

13.64

Stryker Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
YoY EBITDA Growth	Get a 7-Day Free Trial															9.68	47.48	14.29	6.77	12.20

Stryker YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Stryker's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(3.15	-	2.772)	/	\| 2.772 \|
=	13.64 %

Stryker's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2023 )
=	(EBITDA per Share (Q: Dec. 2023 )	-	EBITDA per Share (Q: Dec. 2022 ))	/	\| EBITDA per Share (Q: Dec. 2022 )) \|
=	(0.966	-	0.861)	/	\| 0.861 \|
=	12.20 %

Stryker YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Stryker's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Stryker (BSP:S1YK34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stryker Corp (BSP:S1YK34) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

SYK:USA SYK:Mexico 1SYK:Italy SYK:Germany SYK:Austria

Address

2825 Airview Boulevard, Kalamazoo, MI, USA, 49002

Website

https://www.stryker.com

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.

Stryker (BSP:S1YK34) Headlines

No Headlines